Anthropic's IPO shuts out China and Hong Kong investors
Banks handling Anthropic's IPO refused orders from institutional investors in mainland China and Hong Kong, Bloomberg reported, citing U.S. arms-export rules.
The orders that were turned away
Banks handling Anthropic's IPO have refused to accept orders from institutional investors in mainland China and Hong Kong, or told them allocations are highly unlikely, Bloomberg reported on Friday, citing people familiar with the matter. The restriction is tied in part to the U.S. International Traffic in Arms Regulations, known as ITAR, which control trade in defence products. Anthropic's amended prospectus says some of its AI products could fall under U.S. arms-export rules, and its products are not available in China or Hong Kong.
The deal terms are unchanged. Anthropic is offering 825 million shares at $70 to $78, aiming to raise up to $64.4 billion at a fully diluted valuation of up to $1.4 trillion. Pricing is set for November 18, with trading on Nasdaq under the ticker ANT starting November 19. The book was about 6 times oversubscribed, Bloomberg reported on Thursday.
Why arms-export rules reach an AI IPO
ITAR is the U.S. rulebook for defence trade, and it now shapes who can buy into an AI listing. Anthropic's amended prospectus says some of its AI products could fall under those rules, language that makes bankers cautious, because handling an order that later turns out to breach export controls is a risk no underwriter wants. The banks are not enforcing a rule written in the prospectus: the filing's selling restrictions cover 25 markets, and Hong Kong is not among them. This is the banks' own judgement, made under the shadow of the arms-export regime.
The situation echoes SpaceX's IPO earlier this year, when underwriters were told not to accept orders from buyers in mainland China and Hong Kong under the same rules. Investors there were able to buy SpaceX shares after the listing, and the same may prove true here. Some prospective Anthropic investors are already pursuing workarounds, including a family office tied to a Chinese technology founder attempting to place an order through a British Virgin Islands trust, and others considering special-purpose vehicles and swap arrangements.
The deal goes on, with side doors
The exclusion matters less for the money than for the message. The book was about 6 times oversubscribed, which means demand already far exceeds supply, and the excluded investors are a slice of that demand, not the whole of it. The banks have not restricted clients from submitting orders, and Hong Kong-based investors may still be able to bid through offshore holding structures.
For the placement buyers, nothing changes. Seven chip and cloud suppliers, Google and Nvidia at $10 billion each, AMD at $2.5 billion, Broadcom, Micron and Microsoft at $1 billion each and TSMC at $500 million, are buying $26 billion of non-voting Anthropic shares at the IPO price in a concurrent private placement. Goldman Sachs and Morgan Stanley are the lead underwriters running the deal. Watch pricing on November 18: if the book holds at 6 times oversubscribed with the exclusion in place, the market has priced the geopolitics in.
- 6xOrders vs shares available
- $64.4 billionMaximum the IPO could raise
- $26 billionPrivate placement by chip and cloud suppliers
- $70–$78IPO price range per share
- $1.4 trillionFully diluted valuation at the top of the range
